Category archives for: Stocks

Chief Financial Officer of Interactive Brokers Group, Inc. (NASDAQ:IBKR), Brody Paul Jonathan, sells 934 shares worth $64,622

According to Interactive Brokers Group, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:08 PM, company Chief Financial Officer, Brody Paul Jonathan disclosed selling 934 shares at a cost of $69.19. At the time of this transaction (Feb 04), this trade was worth $64,622 […]

Chief Financial Officer of Interactive Brokers Group, Inc. (NASDAQ:IBKR), Brody Paul Jonathan, sells 933 shares worth $63,863

According to Interactive Brokers Group, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:08 PM, company Chief Financial Officer, Brody Paul Jonathan disclosed selling 933 shares at a cost of $68.45. At the time of this transaction (Feb 03), this trade was worth $63,863 […]

Director of Northwest Bancshares, Inc. (NASDAQ:NWBI), Meegan John P, sells 15,000 shares worth $200,664

According to Northwest Bancshares, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:05 PM, company Director, Meegan John P disclosed selling 15,000 shares at a cost of $13.38. At the time of this transaction (Feb 04), this trade was worth $200,664 in total. As […]

SVP, Gen. Counsel & Secretary of Ligand Pharmaceuticals Inc (NASDAQ:LGND), Berkman Charles S, sells 18,097 shares worth $3,230,376

According to Ligand Pharmaceuticals Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company SVP, Gen. Counsel & Secretary, Berkman Charles S disclosed selling 18,097 shares at a cost of $178.50. At the time of this transaction (Feb 04), this trade was worth […]

Chairman, President and COO of Guardant Health, Inc. (NASDAQ:GH), Talasaz Amirali, sells 6,970 shares worth $1,106,512

According to Guardant Health, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company Chairman, President and COO, Talasaz Amirali disclosed selling 6,970 shares at a cost of $158.75. At the time of this transaction (Feb 04), this trade was worth $1,106,512 in […]

Chairman, President and COO of Guardant Health, Inc. (NASDAQ:GH), Talasaz Amirali, sells 47,053 shares worth $7,469,835

According to Guardant Health, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company Chairman, President and COO, Talasaz Amirali disclosed selling 47,053 shares at a cost of $158.75. At the time of this transaction (Feb 04), this trade was worth $7,469,835 in […]

Chairman, President and COO of Guardant Health, Inc. (NASDAQ:GH), Talasaz Amirali, sells 11,462 shares worth $1,819,222

According to Guardant Health, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company Chairman, President and COO, Talasaz Amirali disclosed selling 11,462 shares at a cost of $158.72. At the time of this transaction (Feb 03), this trade was worth $1,819,222 in […]

Chairman, President and COO of Guardant Health, Inc. (NASDAQ:GH), Talasaz Amirali, sells 76,915 shares worth $12,207,772

According to Guardant Health, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company Chairman, President and COO, Talasaz Amirali disclosed selling 76,915 shares at a cost of $158.72. At the time of this transaction (Feb 03), this trade was worth $12,207,772 in […]

President and COO of Ligand Pharmaceuticals Inc (NASDAQ:LGND), Foehr Matthew W, sells 44,547 shares worth $7,878,582

According to Ligand Pharmaceuticals Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company President and COO, Foehr Matthew W disclosed selling 44,547 shares at a cost of $176.86. At the time of this transaction (Feb 04), this trade was worth $7,878,582 in […]

Sr VP, Gen. Counsel and Secy of Griffon Corp (NYSE:GFF), Kaplan Seth L., sells 13,251 shares worth $322,794

According to Griffon Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company Sr VP, Gen. Counsel and Secy, Kaplan Seth L. disclosed selling 13,251 shares at a cost of $24.36. At the time of this transaction (Feb 05), this trade was worth […]

Featured Press Releases

Photo Gallery

Log in